|
|
News Breaks | | | | February 15, 2013 | | 08:08 EDT |  | MNTA | Momenta Pharma stills sees 2013 operating cash use about $90M
Momenta confirmed its guidance, previously provided in November, for total operating expenses, excluding stock-based compensation and net of collaborative revenues, of approximately $30M per quarter in 2013. For 2013, Momenta is projecting that its net cash usage will average approximately $20M-$24M per quarter for a total operating cash usage of approximately $90M. | |
|
News For MNTA From The Last 14 Days Check below for free stories on MNTA the last two weeks. |
|
|
| There are no results for MNTA |
|
|
|
|
|
|
